BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20369385)

  • 1. Identification of novel serum biomarkers in child nephroblastoma using proteomics technology.
    Zhang Q; Wang J; Dong R; Yang S; Zheng S
    Mol Biol Rep; 2011 Jan; 38(1):631-8. PubMed ID: 20369385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening and identification analysis of serum protein biomarkers in nephroblastoma].
    Wang JX; Yang SB; Liu QL; Dong R; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1259-63. PubMed ID: 19595180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
    Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
    Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
    Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and identification of serum biomarkers of Wilms' tumor in mice using proteomics technology.
    Jia ZK; Wang JX; Yang JJ; Xue R; Zhang D; Wang GN; Ma SL; Duan ZF
    Chin Med J (Engl); 2012 May; 125(10):1727-32. PubMed ID: 22800891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors.
    Wang J; Wang L; Zhang D; Fan Y; Jia Z; Qin P; Yu J; Zheng S; Yang F
    Mol Biol Rep; 2012 May; 39(5):5095-104. PubMed ID: 22160518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and identification of non-inflammatory specific protein markers in Wilms' tumor tissues.
    Zhang J; Guo F; Wang L; Zhao W; Zhang D; Yang H; Yu J; Niu L; Yang F; Zheng S; Wang J
    Arch Biochem Biophys; 2019 Nov; 676():108112. PubMed ID: 31550443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ProteinChip array surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) to identify thymosin beta-4, a differentially secreted protein from lymphoblastoid cell lines.
    Diamond DL; Zhang Y; Gaiger A; Smithgall M; Vedvick TS; Carter D
    J Am Soc Mass Spectrom; 2003 Jul; 14(7):760-5. PubMed ID: 12837598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and identification of potential biomarkers of papillary thyroid carcinoma.
    Fan Y; Shi L; Liu Q; Dong R; Zhang Q; Yang S; Fan Y; Yang H; Wu P; Yu J; Zheng S; Yang F; Wang J
    Mol Cancer; 2009 Sep; 8():79. PubMed ID: 19785722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.
    Cazares LH; Diaz JI; Drake RR; Semmes OJ
    Methods Mol Biol; 2008; 428():125-40. PubMed ID: 18287771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of apolipoprotein C-I as a potential Wilms' tumor marker after excluding inflammatory factors.
    Zhang J; Guo F; Wang L; Zhao W; Zhang D; Yang H; Yu J; Niu L; Yang F; Zheng S; Wang J
    Int J Mol Sci; 2014 Sep; 15(9):16186-95. PubMed ID: 25222555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of serum biomarkers for retinoblastoma using surface enhanced laser desorption/ionization protein chip system].
    Yang Y; Xiao X; Wu K; Wang J; Zhou L; Yang H; Li Y; He D; Zhang P
    Yan Ke Xue Bao; 2007 Sep; 23(3):136-42. PubMed ID: 18041180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A pilot investigation on serum protein fingerprinting of nasopharyngeal carcinoma].
    Huang XW; Zhou W; Chen J; Chu HQ; Xiao CW; Hua XY; Zhang P; Li HQ; Cui YH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):509-12. PubMed ID: 21924105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.
    Ye B; Cramer DW; Skates SJ; Gygi SP; Pratomo V; Fu L; Horick NK; Licklider LJ; Schorge JO; Berkowitz RS; Mok SC
    Clin Cancer Res; 2003 Aug; 9(8):2904-11. PubMed ID: 12912935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of proteomics-identified CCL18 and CXCL1 as circulating tumor markers for differential diagnosis between ovarian carcinomas and benign pelvic masses.
    Wang Q; Li D; Zhang W; Tang B; Li QQ; Li L
    Int J Biol Markers; 2011; 26(4):262-73. PubMed ID: 21928244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A primary proteomic analysis of serum from patients with nonfunctioning pituitary adenoma.
    Hu X; Zhang P; Shang A; Li Q; Xia Y; Jia G; Liu W; Xiao X; He D
    J Int Med Res; 2012; 40(1):95-104. PubMed ID: 22429349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers.
    Rai AJ; Stemmer PM; Zhang Z; Adam BL; Morgan WT; Caffrey RE; Podust VN; Patel M; Lim LY; Shipulina NV; Chan DW; Semmes OJ; Leung HC
    Proteomics; 2005 Aug; 5(13):3467-74. PubMed ID: 16052624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.